Type 2 diabetesthe most common indication for GLP-1 therapyis independently associated with a two- to threefold increased risk of ED due to neuropathy, endothelial dysfunction, and reduced nitric oxide availability
Given the uncertainties outlined above, speaking to a GP or pharmacist before combining NAD+ supplements with retatrutide or any GLP-1-based therapy is strongly advisable
Lala, V., Zubair, M., & Minter, D
However, FMT is not without risks: it may transmit opportunistic fungi (e.g., Candida spp.) and multidrug-resistant bacteria, potentially leading to severe infections, particularly in immunocompromised recipients 165,184